EP2866825
USE OF LONG-ACTING GLP-1 PEPTIDES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.6.2013EP published:
8.4.2020EP application number:
13737808.9
EPO information:
European Patent Register
Max expiry date:
20.6.2033
Title:
USE OF LONG-ACTING GLP-1 PEPTIDES
Timeline
Today
21.6.2013EP application
8.4.2020EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
JENSEN, Christine BjørnAddress:
DK-2880 Bagsværd, DK
Name:
RASMUSSEN, Mads FrederikAddress:
DK-2880 Bagsværd, DK
Name:
ZDRAVKOVIC, MilanAddress:
DK-2880 Bagsværd, DK
Name:
KRISTENSEN, PeterAddress:
DK-2880 Bagsværd, DK
Priority
Number:
12174535Date:
1.7.2012Country:
EP
Number:
201261694837 PDate:
30.8.2012Country:
US
Number:
12186781Date:
1.10.2012Country:
EP
Number:
201261708162 PDate:
1.10.2012Country:
US
Classification
Categories:
A61K 38/26, A61P 3/04